Garmin announced a suite of apps that will allow people with diabetes who use the Dexcom G6 continuous glucose monitor (CGM) to view glucose levels and trends on their smartwatch.
The Dexcom Connect IQ apps allow users with a compatible smartwatch or cycling computer to view their glucose levels as well as a three-hour history to get a better picture of where their levels may be headed during the...
UK digital health startup Habitual has scored $2.3 million (£1.7M) in seed round funding.
The London-based firm offers a weight loss programme for people with type 2 diabetes or prediabetes, which combines evidence-based food replacement with digital support.
Berlin-based Atlantic Food Labs, led the round with existing investors Seedcamp and MMC also participating.
Oxford Seed Fund, which is an...
Israel-based DreaMed scored another FDA clearance, expanding the availability of its AI-supported diabetes care platform to Type 2 patients.
The Advisor Pro Al Clinical Decision Support System helps healthcare providers manage the insulin needs of patients who use insulin pumps or injections and monitor their glucose levels using a continuous glucose monitor and/or blood glucose meters.
The...
Digital chronic care company Welldoc has received its ninth FDA 510(k) clearance for its diabetes management platform BlueStar.
The new clearance, which was announced by Welldoc Wednesday, but approved by the FDA earlier this month, expands its earlier approval for insulin dosing support to include bolus and premixed insulin titration for Type 2 diabetes.
The Insulin Adjustment Program with...
Virtual diabetes clinic 9am.health launched Monday with $3.7 million in seed funding. Investors in the seed round include Founders Fund, Define Ventures, Speedinvest and iSeed Ventures.
"Over the last few decades, there have been great technologies and medications developed that have helped many of us living with diabetes. But, if you look at the average standard of care for people living with...
Third-party digital health companies can now integrate Dexcom’s continuous glucose monitoring data into their platforms and devices in real-time thanks to a new FDA clearance for the company’s Partner Web APIs.
The data integration capabilities are available to companies on an invite-only basis. So far, wearable device-maker Garmin and chronic-condition-management company Livongo have entered the...
Diabetes care has changed dramatically in recent years, thanks to technological developments, but some of the metrics used in the disease’s management remain outdated. That’s why Dexcom created The Global Movement for Time in Range, an educational campaign to raise awareness and adoption of time in range as the standard of care in diabetes management.
Time in range is the percentage of time spent...
A Dubai-based specialist diabetes clinic has released its very first report on the outcomes of its care model, demonstrating that continuous data monitoring is advantageous in dramatically improving the health of those with the condition.
GluCare Integrated Diabetes Center, which describes itself as the “world’s first healthcare provider to employ integrated continuous data monitoring” and the “...
Better Therapeutics, a nutritional cognitive behavioral therapy digital therapeutics company, announced plans today to go public by merging with special purpose acquisition company Mountain Crest Acquisition Corp II.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company. It includes a $50 million private investment in...
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
_0.jpg?itok=213jxKpx)
